BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $531,079 | +2.7% | 88,661 | +21.4% | 0.00% | 0.0% |
| Q3 2023 | $517,236 | +267.5% | 73,056 | +265.5% | 0.00% | – |
| Q2 2023 | $140,730 | -38.4% | 19,990 | -27.0% | 0.00% | – |
| Q1 2023 | $228,516 | -92.4% | 27,400 | -89.6% | 0.00% | -100.0% |
| Q4 2022 | $3,014,705 | +66.8% | 262,605 | +83.1% | 0.01% | +60.0% |
| Q3 2022 | $1,807,000 | +678.9% | 143,389 | +554.1% | 0.01% | – |
| Q2 2022 | $232,000 | -65.9% | 21,920 | -47.7% | 0.00% | -100.0% |
| Q1 2022 | $681,000 | -83.1% | 41,932 | -85.5% | 0.00% | -84.6% |
| Q4 2021 | $4,019,000 | -57.9% | 290,122 | -56.4% | 0.01% | -60.6% |
| Q3 2021 | $9,553,000 | +4.2% | 664,803 | +14.6% | 0.03% | -8.3% |
| Q2 2021 | $9,171,000 | +4049.8% | 580,097 | +1861.6% | 0.04% | +3500.0% |
| Q4 2020 | $221,000 | +163.1% | 29,572 | -29.7% | 0.00% | 0.0% |
| Q1 2020 | $84,000 | -46.2% | 42,086 | -6.7% | 0.00% | 0.0% |
| Q4 2019 | $156,000 | +1633.3% | 45,086 | +3521.4% | 0.00% | – |
| Q3 2018 | $9,000 | -97.2% | 1,245 | -96.7% | 0.00% | -100.0% |
| Q1 2017 | $317,000 | +1409.5% | 37,700 | +1785.0% | 0.00% | – |
| Q4 2015 | $21,000 | -48.8% | 2,000 | -44.4% | 0.00% | – |
| Q3 2015 | $41,000 | +485.7% | 3,600 | +620.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |